Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Regular ✕Edelweiss Recently Listed IPO Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCEdelweiss
NAV₹22.8170₹33.4822
NAV date20 Nov 202620 Nov 2026
History3.1 years8.7 years
Expense ratio2.1%2.7%
Stars★★★★★★★★★★
Growth Score93.9044.70

Returns

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
1 month+12.87%+5.80%
3 months+6.85%+2.08%
6 months+17.20%+19.60%
YTD+32.43%+23.82%
1 year+30.73%+22.21%
3 years (CAGR)+29.16%+15.66%
5 years (CAGR)—+9.59%
10 years (CAGR)——
Since launch+30.28%+14.82%

Risk

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Volatility15.8%20.9%
Downside volatility8.6%13.1%
Sharpe1.440.44
Sortino2.640.70
Calmar1.940.63
Return / risk1.850.75
Deepest fall−15.07%−32.34%
Days to recover133155
Below its high+0.00%−1.65%

Against benchmark

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Alpha+6.36%+4.43%
Beta0.970.97
R²85.0%56.3%
Up capture106.7%111.0%
Down capture74.4%96.2%
Tracking error6.1%13.8%
Information ratio0.970.31
Treynor0.220.09

Consistency

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Best 1-year+64.96%+97.69%
Middle 1-year+21.84%+16.18%
Worst 1-year+0.52%−24.34%
1-year periods with a loss0.0%26.2%
Middle 3-year+28.68%+17.58%
Positive months69.4%66.7%
Best day+3.19%+3.68%
Worst day−3.62%−5.79%
Worst 5% day−1.50%−1.94%
Positive days58.1%57.4%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
5-year XIRR—+16.40%
5-year value—₹9,11,471
3-year XIRR+26.26%+16.90%
1-year XIRR+39.84%+33.64%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth